Merck Mmr

M-M-R II measles, mumps and rubella virus vaccine, live, attenuated, Merck Std. is supplied as a sterile, lyophilized, light yellow compact crystalline plug in a single-dose vial. The diluent STERILE DILUENT For Merck Sharp amp Dohme LLC live, attenuated, virus vaccines is a

To report SUSPECTED ADVERSE REACTIONS, contact Merck Sharp amp Dohme LLC at 1-877-888-4231 or VAERS at 1-800-822-7967 7.4 Use with Other Live Viral Vaccines 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.4 Pediatric Use 8.5 Geriatric Use 11 DESCRIPTION 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action

Enroll locations into Merck pricing programs and maintain account and location information associated with user accounts and organizations. Merck Access Program. The Merck Access Program may be able to help answer questions about access and support. Measles, Mumps, Rubella and Varicella Virus Vaccine Live

Manufacturer Merck Sharp amp Dohme LLC Indication M-M-R II is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.

Contraindications for the MMR vaccine include. A severe allergic reaction eg, anaphylaxis after a previous dose or to a vaccine component, including neomycin after a previous dose or to a vaccine component, including neomycin Known severe primary or acquired immunodeficiency eg, due to leukemia, lymphomas, solid tumors, tumors that affect bone marrow or the lymphatic system, AIDS, severe

You can also begin ordering by calling into the Merck Vaccines Customer Care line 877.VAX.MERCK 877.829.6372, or through your preferred wholesalerdistributor. For a list of Merck authorized distributors please go to Authorized distributors - Merck.com. default-sum-open-background-color.

The MMR vaccine is given as an injection under the skin. As a part of routine childhood vaccinations, 2 doses are given at age 12 to 15 months and typically at age 4 to 6 years.. All adults who were born in or after 1957 should be given one dose of the vaccine unless they have documentation of vaccination with one or more doses of MMR or unless laboratory tests show they are immune.

Three vaccines containing measles, mumps, and rubella virus are licensed for use in the United States. M-M-R II is a combination measles, mumps, and rubella MMR vaccine manufactured by Merck amp Co, Inc. PRIORIX is a combination measles, mumps, and rubella MMR vaccine manufactured by GlaxoSmithKline Biologicals GSK.

With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly Merck NYSE MRK, known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration FDA has approved the addition of the intramuscular IM route of administration to the United States Product